Rapid bidirectional modulation of mRNA expression and export accompany long-term facilitation and depression of Aplysia synapses.
Serotonin (5-HT) and the neuropeptide Phe-Met-Arg-Phe-amide (FMRFa) modulate synaptic efficacy of sensory neurons (SNs) of Aplysia in opposite directions and for long duration. Both long-term responses require changes in mRNA and protein synthesis. The SN-specific neuropeptide, sensorin A, is a gene product that appears to be increased by 5-HT and decreased by FMRFa. We examined whether changes in sensorin A mRNA levels in the cell body and neurites of SNs accompany long-term facilitation and depression. Both 5-HT and FMRFa evoked rapid changes in sensorin A mRNA levels in the SN cell bodies: an increase with 5-HT and a decrease with FMRFa. Parallel changes in sensorin A mRNA levels in SN neurites were detected 2 h and 4 h later. These rapid changes in mRNA expression and net export required the presence of the appropriate target motor cell L7. The neuromodulators failed to produce changes in mRNA expression or export when SNs were cultured alone or with the inappropriate target cell L11. The changes in mRNA expression were transient because mRNA levels returned to control values 24 h after treatment, while synaptic efficacy remained altered by the respective treatments. These results indicate that two neuromodulators produce distinct, but transient, target-dependent effects on expression and export of a cell-specific mRNA that correlate with changes in synaptic plasticity.
Sun
Z Y
ZY
Center for Neurobiology & Behavior, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, 722 West 168th Street, New York, New York 10032, USA.
Wu
F
F
Schacher
S
S
D000818:Animals; D001048:Aplysia / Q000166:cytology / Q000378:metabolism*; D002451:Cell Compartmentation / Q000502:physiology; D019835:FMRFamide / Q000378:metabolism / Q000494:pharmacology; D017952:Ganglia, Invertebrate / Q000166:cytology / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000502:physiology*; D019476:Insect Proteins / Q000235:genetics*; D017774:Long-Term Potentiation / Q000187:drug effects / Q000502:physiology; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000166:cytology / Q000378:metabolism*; D009479:Neuropeptides / Q000235:genetics*; D014176:Protein Biosynthesis / Q000502:physiology*; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
D019476:Insect Proteins; D009479:Neuropeptides; D012333:RNA, Messenger; C419310:sensorin A protein, Aplysia; D012701:Serotonin; D019835:FMRFamide